Canada markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
38.21-1.73 (-4.33%)
At close: 04:00PM EDT
38.21 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.52B
Enterprise Value 1.70B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)323.22
Price/Book (mrq)3.00
Enterprise Value/Revenue 279.43
Enterprise Value/EBITDA -17.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.60
52-Week Change 313.65%
S&P500 52-Week Change 326.49%
52 Week High 353.18
52 Week Low 322.11
50-Day Moving Average 340.53
200-Day Moving Average 334.61

Share Statistics

Avg Vol (3 month) 3904.72k
Avg Vol (10 day) 3570.35k
Shares Outstanding 565.91M
Implied Shares Outstanding 666.98M
Float 865.73M
% Held by Insiders 10.34%
% Held by Institutions 1107.30%
Shares Short (Apr 30, 2024) 46.99M
Short Ratio (Apr 30, 2024) 411.33
Short % of Float (Apr 30, 2024) 412.28%
Short % of Shares Outstanding (Apr 30, 2024) 410.60%
Shares Short (prior month Mar 28, 2024) 46.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 11, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 11, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-26,030.77%

Management Effectiveness

Return on Assets (ttm)-15.73%
Return on Equity (ttm)-25.39%

Income Statement

Revenue (ttm)6.07M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)-83.90%
Gross Profit (ttm)N/A
EBITDA -147.12M
Net Income Avi to Common (ttm)-144.88M
Diluted EPS (ttm)-2.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)823.85M
Total Cash Per Share (mrq)12.5
Total Debt (mrq)2.11M
Total Debt/Equity (mrq)0.25%
Current Ratio (mrq)31.77
Book Value Per Share (mrq)12.72

Cash Flow Statement

Operating Cash Flow (ttm)-119.36M
Levered Free Cash Flow (ttm)-54.98M